Insider plans sale of 17,700 common shares

An insider of AMRC filed a notice of proposed sale of 17,700 shares of common stock, to be sold through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $589,233.

Rhea-AI Filing Summary

An insider of AMRC filed a notice of proposed sale of 17,700 shares of common stock, to be sold through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $589,233. The company had 34,797,456 shares outstanding of this class at the time referenced. The shares come from a same-day cash exercise of stock options on 02/13/2026, matching the approximate sale date. The filer also reported recent 10b5-1 plan sales of 200 shares for $6,800 on 02/12/2026 and 100 shares for $3,400 on 01/28/2026. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction does this AMRC Form 144 disclose?

The filing discloses a planned sale of 17,700 AMRC common shares. These shares result from a same-day cash exercise of stock options on 02/13/2026, with the sale intended to occur around that date.

What is the value of the AMRC shares the insider plans to sell?

The insider plans to sell 17,700 common shares with an aggregate market value of $589,233. This value is based on the market price used in the Form 144 and reflects the total for the proposed transaction.

How many AMRC shares are outstanding compared to the planned sale?

The filing states there are 34,797,456 AMRC common shares outstanding. The proposed sale of 17,700 shares represents a small fraction of this total, giving context to the relative size of the insider’s planned transaction.

How were the AMRC shares to be sold under this Form 144 acquired?

The 17,700 shares to be sold were acquired through a cash exercise of stock options on 02/13/2026. The acquisition date, exercise method, and the sale’s approximate date all match in the disclosure.

What recent 10b5-1 sales by the AMRC insider are disclosed?

The filing lists two 10b5-1 plan sales: 200 common shares sold on 02/12/2026 for $6,800 and 100 common shares sold on 01/28/2026 for $3,400. These reflect recent, smaller transactions by the same seller.

What representation does the AMRC seller make about inside information?

By signing, the seller represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is a standard part of the Form 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 04:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001195025
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Ameresco, Inc.
SEC File Number	001-34811
Address of Issuer	111 Speen Street, Suite 410 Framingham MASSACHUSETTS 01701
Phone	5086612200
Name of Person for Whose Account the Securities are To Be Sold	NICKOLAS STAVROPOULOS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	17700	589233.00	34797456	02/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Exercise of Stock Options	Issuer			17700	02/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for NICKOLAS STAVROPOULOS 111 Speen Street, Suite 410 Framingham MA 01701	Common	02/12/2026	200	6800.00
10b5-1 Sales for NICKOLAS STAVROPOULOS 111 Speen Street, Suite 410 Framingham MA 01701	Common	01/28/2026	100	3400.00

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	02/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Nickolas Stavropoulos
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)